ELIZABETH NAVARRO: Open Payments
NPI 1962170316 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 35 payments from 8 companies in 2025. Trend: 2023 $547 · 2024 $965 · 2025 $1,175
Food & beverage: $1,085Education: $90
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 11 | $380 |
| Janssen Biotech, Inc. | 6 | $274 |
| Merck Sharp & Dohme LLC | 9 | $211 |
| AstraZeneca Pharmaceuticals LP | 1 | $124 |
| PFIZER INC. | 3 | $77 |
| Astellas Pharma US Inc | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $39 |
| IMMUNITYBIO, INC. | 1 | $24 |
Products named: Lenvima, KEYTRUDA, ERLEADA, RYBREVANT, Padcev, XTANDI, ORGOVYX, LYNPARZA.
Industry payments across IN — which companies pay providers there.
